Köhler-Forsberg, K., Jorgensen, A., Dam, V. H., Stenbæk, D. S., Fisher, P. M., Ip, C., . . . Frokjaer, V. G. (2020). Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol. Frontiers in psychiatry, 11, 641. https://doi.org/10.3389/fpsyt.2020.00641
Citácia podle Chicago (17th ed.)Köhler-Forsberg, Kristin, et al. "Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol." Frontiers in Psychiatry 11 (2020): 641. https://doi.org/10.3389/fpsyt.2020.00641.
Citácia podľa MLA (8th ed.)Köhler-Forsberg, Kristin, et al. "Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol." Frontiers in Psychiatry, vol. 11, 2020, p. 641, https://doi.org/10.3389/fpsyt.2020.00641.